| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.12 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $82.24 $66.19 (20%) | 🛒 Add to cart |
| 90 | $1.01 | $123.36 $91.27 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $164.48 $117.34 (29%) | 🛒 Add to cart |
| 180 | $0.94 | $246.72 $168.49 (32%) | 🛒 Add to cart |
| 270 | $0.90 | $370.08 $243.71 (34%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $493.44 $317.93 (36%) | 🛒 Add to cart |
Synonyms | |||
More info:
alli: Clinically Proven Weight Loss Aid - Evidence-Based Review
Orlistat, marketed as alli in its over-the-counter 60 mg formulation, represents a significant class of weight management agents known as lipase inhibitors. Unlike systemic appetite suppressants or stimulants, alli operates locally within the gastrointestinal tract, specifically targeting dietary fat. Its development marked a pivotal shift towards non-systemic pharmacological interventions for obesity, a chronic and multifactorial disease. For healthcare professionals and patients alike, understanding its precise mechanism and appropriate use is crucial for achieving meaningful, sustainable weight loss outcomes, which is why a deep dive into its monograph is warranted.
Abhigra: Advanced Neuro-Endocrine Support for Stress Adaptation - Evidence-Based Review
Before we dive into the formal monograph, let me give you the real story behind Abhigra. We initially developed it as a specialized anti-inflammatory matrix for post-surgical recovery, but our first pilot study with orthopedic patients showed something unexpected – the most significant improvements were actually in mood stabilization and sleep architecture. Dr. Chen from our team was convinced we’d contaminated the samples, but the cortisol and cytokine panels didn’t lie.
aciclovir
Aciclovir represents one of those foundational antiviral agents that completely reshaped our approach to herpesvirus management when it first emerged. As a nucleoside analogue, its mechanism is elegantly specific – it gets phosphorylated by viral thymidine kinase in infected cells, then incorporated into viral DNA where it acts as a chain terminator. What’s fascinating is how this selectivity minimizes damage to uninfected host cells, giving us that therapeutic window we desperately needed in antiviral therapy.
Alkeran: Potent Cytotoxic Therapy for Hematologic Malignancies - Evidence-Based Review
Melphalan, known commercially as Alkeran, represents one of the foundational chemotherapeutic agents in modern oncology, specifically belonging to the nitrogen mustard class of alkylating agents. It’s primarily utilized in hematologic malignancies and certain solid tumors, functioning by cross-linking DNA strands to prevent cellular replication. Unlike many newer targeted therapies, its mechanism is non-specific, affecting both cancerous and rapidly dividing normal cells, which explains its significant toxicity profile. Having been in clinical use since the 1960s, it remains a cornerstone in conditioning regimens for hematopoietic stem cell transplantation and in the management of multiple myeloma, particularly in patients ineligible for autologous transplantation.
Allopurinol: Effective Uric Acid Control for Gout and Hyperuricemia - Evidence-Based Review
Allopurinol is a xanthine oxidase inhibitor, a medication that fundamentally alters the body’s production of uric acid. It’s not a supplement or a device in the traditional sense, but a prescription drug with a very specific and critical role in managing chronic hyperuricemia, which is the underlying cause of gout. For over half a century, it’s been the cornerstone of urate-lowering therapy, preventing the formation of uric acid crystals that deposit in joints, kidneys, and other tissues, causing immense pain and long-term damage.
alphagan
Brimonidine tartrate ophthalmic solution 0.15% - what we commonly call Alphagan - represents one of those interesting cases where a medication developed for one purpose found its true calling elsewhere. Originally investigated as a systemic antihypertensive, its ocular formulation became the breakthrough for glaucoma management that we rely on today. The transition from oral to topical administration wasn’t straightforward - we had significant debates about concentration optimization and preservative systems that dragged on for months.
antabuse
Disulfiram, known commercially as Antabuse, represents one of the oldest and most psychologically potent tools in the addiction medicine arsenal. It’s not a typical medication that works by reducing cravings or blocking pleasurable effects—rather, it creates a powerful negative reinforcement by making the consumption of alcohol physically unbearable. When I first encountered Antabuse in my addiction psychiatry rotation back in ‘08, I thought it was almost medieval in its approach. But over fifteen years of practice, I’ve watched this unassuming tablet literally save lives that were careening toward liver failure or fatal accidents.
Antivert: Effective Vertigo and Motion Sickness Relief - Evidence-Based Review
Product Description: Antivert represents one of the most established pharmacological interventions for vestibular disorders, specifically formulated as meclizine hydrochloride. This antihistamine and antiemetic agent has been a cornerstone in managing vertigo and motion sickness for decades, offering predictable symptom relief through central nervous system modulation. Unlike newer supplements with limited regulatory oversight, Antivert maintains FDA approval status with extensive clinical documentation supporting its efficacy profile across multiple patient populations. The standard 12.
Arcoxia: Targeted Pain and Inflammation Control for Arthritis - Evidence-Based Review
Product Description Arcoxia (etoricoxib) represents Merck’s second-generation COX-2 selective inhibitor, developed as a successor to earlier NSAIDs with improved gastrointestinal safety profiles. This prescription medication exists in 60mg, 90mg, and 120mg tablets, specifically engineered for chronic inflammatory conditions where traditional NSAIDs pose bleeding risks. What’s fascinating about Arcoxia’s development was our team’s obsession with the COX-2 selectivity ratio - we achieved nearly 106-fold selectivity for COX-2 over COX-1, compared to celecoxib’s 30-fold.